Melanoma

## [1] 494

Gene Variant	Total Cases	Percent of Cases (%)
BRAF	183	37.0
NRAS	152	30.8
TP53	118	23.9
NF1	82	16.6
ARID2	53	10.7
CDKN2A	53	10.7
TERT	46	9.3
PTEN	40	8.1
KIT	28	5.7
CTNNB1	25	5.1
RAC1	25	5.1
MAP2K1	24	4.9
ARID1A	23	4.7
RB1	18	3.6
ATM	15	3.0
KRAS	15	3.0
SETD2	15	3.0
IDH1	14	2.8
KDR	14	2.8
DNMT3A	13	2.6
TET2	13	2.6
EPHA3	12	2.4
BRCA1	11	2.2
GNAQ	11	2.2
SF3B1	11	2.2
APC	10	2.0
CHEK2	10	2.0
PIK3R1	9	1.8
ATRX	8	1.6
BRCA2	8	1.6
KMT2C	8	1.6
PIK3CB	8	1.6
EZH2	7	1.4
EGFR	6	1.2
FBXW7	6	1.2
PBRM1	6	1.2
PIK3CA	6	1.2
PTPN11	6	1.2
RAF1	6	1.2
SLIT2	6	1.2
STAG2	6	1.2
STK11	6	1.2
SYK	6	1.2
CDK4	5	1.0
ERBB4	5	1.0
ERCC2	5	1.0
HRAS	5	1.0
MET	5	1.0
MTOR	5	1.0
NOTCH1	5	1.0
SMARCA4	5	1.0
GNA11	4	0.8
MSH2	4	0.8
MSH6	4	0.8
NOTCH2	4	0.8
RAD50	4	0.8
TSC2	4	0.8
AKT3	3	0.6
BRIP1	3	0.6
CIC	3	0.6
CREBBP	3	0.6
DDR2	3	0.6
EIF1AX	3	0.6
ERBB3	3	0.6
FGFR2	3	0.6
FUBP1	3	0.6
JAK1	3	0.6
MEN1	3	0.6
NBN	3	0.6
NF2	3	0.6
PTCH1	3	0.6
TRAF7	3	0.6
WT1	3	0.6
ARAF	2	0.4
B2M	2	0.4
CSF1R	2	0.4
KDM5C	2	0.4
KDM6A	2	0.4
MAP2K4	2	0.4
MED12	2	0.4
MRE11A	2	0.4
MUTYH	2	0.4
NOTCH3	2	0.4
PALB2	2	0.4
SMAD4	2	0.4
U2AF1	2	0.4
ABL1	1	0.2
ALK	1	0.2
AR	1	0.2
AXIN1	1	0.2
CDH1	1	0.2
DAXX	1	0.2
EP300	1	0.2
ERBB2	1	0.2
ESR2	1	0.2
FGFR1	1	0.2
FLT3	1	0.2
GATA3	1	0.2
GNAS	1	0.2
JAK2	1	0.2
JAK3	1	0.2
KMT2D	1	0.2
MCL1	1	0.2
MLH1	1	0.2
MLH3	1	0.2
MYC	1	0.2
NKX2-1	1	0.2
NTRK3	1	0.2
PDGFRA	1	0.2
POLD1	1	0.2
POT1	1	0.2
RAD51	1	0.2
RAD51B	1	0.2
RAD51D	1	0.2
RET	1	0.2
RHOA	1	0.2
RNF43	1	0.2
SDHC	1	0.2
SMO	1	0.2
SPOP	1	0.2
TGFBR2	1	0.2
TSC1	1	0.2
XRCC2	1	0.2